Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
DNA Damage
100%
Ureter Stone
66%
Meta-Analysis
52%
Leukocyte
36%
Male Infertility
34%
Systematic Review
34%
Urologist
33%
Ureteroscopy
33%
Tamsulosin
33%
Computer Assisted Tomography
33%
Male Fertility
33%
Male Reproductive Health
33%
Substance Abuse
22%
Hyperthermia
22%
Prevalence
22%
Cross Sectional Study
19%
Multivariate Analysis
19%
Lower Urinary Tract Symptom
16%
Predictive Factor
16%
Pain Assessment
16%
Ureter
16%
Cell Count
16%
Medical Record
16%
Hexachlorophene
16%
Embryo Development
16%
Radiological Finding
16%
Obstruction
16%
Benign Prostatic Hyperplasia
16%
Fluoroscopy
16%
DNA Fragmentation
16%
Reactive Oxygen Species
16%
Sexual Characteristic
16%
Randomized Controlled Trial
16%
Cyst
16%
Antioxidant Capacity
14%
Erectile Dysfunction
13%
Funnel Plot
11%
TUNEL Assay
11%
Mental Stress
11%
Cell Phone Use
11%
Semen Analysis
9%
Antibiotics
8%
Prospective Study
7%
Random Effects Model
7%
Reactive Oxygen Species
7%
Effect Size
7%
Age Groups
7%
Pathophysiology
6%
Assisted Reproductive Technology
6%
Sperm Motility
6%
Nursing and Health Professions
Saudi Arabia
57%
Phosphodiesterase V Inhibitor
50%
Meta Analysis
33%
Systematic Review
33%
Social Media
33%
Urologist
29%
Education
20%
Data Processing
19%
Cross-Sectional Survey
19%
Higher Education
19%
Semen Analysis
18%
Teaching Hospital
16%
Prevalence
16%
Accident Prevention
16%
Reactive Oxygen Metabolite
16%
World Health Organization
16%
Antibiotic Resistance
16%
Cystitis
16%
Efficacy
16%
Reference Value
16%
Paternal Age
16%
Sexual Dysfunction
16%
Confidence Interval
16%
Antioxidant Capacity
12%
Self Evaluation
11%
Practice Guideline
10%
Fluoroscopy
7%
Ampicillin
6%
Cotrimoxazole
6%
Erectile Dysfunction
5%
Exploratory Factor Analysis
5%
Construct Validity
5%
Cronbach Alpha Coefficient
5%
Decision-Making
5%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphodiesterase V Inhibitor
50%
Pelvis Pain Syndrome
33%
Chronic Prostatitis
33%
Medical Prescription
19%
Cystitis
16%
Prostate Hypertrophy
16%
Antimicrobial Resistance
16%
Randomized Controlled Trial
16%
Escherichia coli
10%
Antibiotics
7%
Cotrimoxazole
6%
Aztreonam
6%
Cefalotin
6%
Ampicillin
6%
